FRZB and non-small cell lung carcinoma: Increased expression of Wnt ligands (WNT1, 2, 7A) along with decreased expression of Wnt inhibitors (DKK3 and SFRP3) was observed in non-small cell lung cancer [47], [49], [51]–[53].